MVA-BN RSV: Phase II started

Bavarian Nordic began a single-blind, placebo-controlled, U.S. Phase II trial to evaluate 2 dose levels of MVA-BN RSV given once or twice 4 weeks apart in about 400 healthy volunteers ages >=55....